Thomas Givens - Rougemont NC Paul Braun - Durham NC Lisa Beck - Durham NC
Assignee:
bioMerieux, Inc. - Durham NC
International Classification:
G01N 2100
US Classification:
702 22, 702 28, 702 30, 702 32
Abstract:
A method for presenting relationships between data from a thrombosis-hemostasis assay on an unknown sample and data from a purality of assays on known samples, which can be in the form of a topological feature map wherein spatial locations within the map correspond to intrinsic features of the known samples. The position of the unknown sample is superimposed on the positions of the known samples. An alternative presentation is showing the distance of each of a purality of predictor variables from an unknown sample to the mean values of a known population.
Method And Apparatus For Predicting The Presence Of An Abnormal Level Of One Or More Proteins In The Clotting Cascade
Paul Braun - Durham NC Thomas B. Givens - Rougemont NC Timothy J. Fischer - Oro Valley AZ
Assignee:
bioMerieux - Durham NC
International Classification:
G01N 2100
US Classification:
702 22, 702 30, 702 32, 702 19, 436 69
Abstract:
A method is disclosed for predicting the presence of an abnormal level of one or more proteins in the clotting cascade from at least one time-dependent measurement profile. At least one time-dependent measurement on an unknown sample is performed and a respective property of said sample is measured over time so as to derive a time-dependent measurement profile. A set of a plurality of predictor variables are defined which sufficiently define the data of the time-dependent measurement profile. A model is then derived that represents the relationship between the abnormality and the set of predictor variables. Subsequently, the model is utilized to predict which protein or proteins in the clotting cascade are at an abnormal level, with the prediction being a more informative prediction than clot time alone.
Method For Predicting The Presence Of Congenital And Therapeutic Conditions From Coagulation Screening Assays
Thomas Givens - Rougemont NC, US Paul Braun - Durham NC, US Timothy Fischer - Raleigh NC, US
International Classification:
G06F019/00 G01N031/00
US Classification:
702/022000
Abstract:
A method and apparatus are disclosed for predicting the presence of at least one congenital or acquired imbalance or therapeutic condition associated with thrombosis/hemostasis from at least one time-dependent measurement profile. At least one time-dependent measurement on an unknown sample is performed and a respective property of said sample is measured over time so as to derive a time-dependent measurement profile. A set of a plurality of predictor variables are defined which sufficiently define the data of the time-dependent measurement profile. A model is then derived that represents the relationship between the congenital or acquired imbalance or therapeutic condition, and the set of predictor variables. Subsequently, the model is utilized to predict the existence of the congenital or acquired imbalance or therapeutic condition in the unknown sample.
Method And Apparatus For Predicting The Presence Of Congenital And Acquired Imbalances And Therapeutic Conditions
Thomas B. Givens - Rougemont NC Paul Braun - Durham NC Timothy J. Fischer - Raleigh NC
Assignee:
Akzo Nobel N.V. - Arnhem
International Classification:
G01N 3349 G06F 1900
US Classification:
364497
Abstract:
A method and apparatus are disclosed for predicting the presence of at least one congenital or acquired imbalance or therapeutic condition associated with thrombosis/hemostasis from at least one time-dependent measurement profile. At least one time-dependent measurement on an unknown sample is performed and a respective property of said sample is measured over time so as to derive a time-dependent measurement profile. A set of a plurality of predictor variables are defined which sufficiently define the data of the time-dependent measurement profile. A model is then derived that represents the relationship between the congenital or acquired imbalance or therapeutic condition, and the set of predictor variables. Subsequently, the model is utilized to predict the existence of the congenital or acquired imbalance or therapeutic condition in the unknown sample.
Method And Apparatus For Predicting The Presence Of An Abnormal Level Of One Or More Proteins In The Clotting Cascade
Paul Braun - Durham NC Thomas B. Givens - Rougemont NC Timothy J. Fischer - Raleigh NC
Assignee:
Akzo Nobel N.V.
International Classification:
G01N 2100
US Classification:
702 22
Abstract:
A method is disclosed for predicting the presence of an abnormal level of one or more proteins in the clotting cascade from at least one time-dependent measurement profile. At least one time-dependent measurement on an unknown sample is performed and a respective property of said sample is measured over time so as to derive a time-dependent measurement profile. A set of a plurality of predictor variables are defined which sufficiently define the data of the time-dependent measurement profile. A model is then derived that represents the relationship between the abnormality and the set of predictor variables. Subsequently, the model is utilized to predict which protein or proteins in the clotting cascade are at an abnormal level, with the prediction being a more informative prediction than clot time alone.
Method For Predicting The Presence Of Congenital And Therapeutic Conditions From Coagulation Screening Assays
Thomas B. Givens - Rougemont NC Paul Braun - Durham NC Timothy J. Fischer - Raleigh NC
Assignee:
Akzo Nobel N.V. - Arnhem
International Classification:
G01N 2100
US Classification:
702 22
Abstract:
A method and apparatus are disclosed for predicting the presence of at least one congenital or acquired imbalances or therapeutic condition associated with thrombosis/hemostasis from at least one time-dependent measurement profile. At least one time-dependent measurement in a sample is performed and a respective property of sample is measured over time so as to derive a time-dependent measurement profile. A set of a plurality of predictor variables are defined which sufficiently define the data of the time-dependent measurement profile. A model is then derived that represents the relationship between the congenital or acquired imbalance or therapeutic condition, and the set of predictor variables. Subsequently, the model is utilized to predict the existence of the congenital or acquired imbalance or therapeutic condition in a sample.
Gregory D. Lewis - Cary NC Roger G. Roberts - Raleigh NC Thomas B. Givens - Rougemont NC
Assignee:
Akzo Nobel N.V. - Arnhem
International Classification:
G01N 2113
US Classification:
422 66
Abstract:
A mechanism is provided for loading the cassette into an operative relationship with a machine for dispensing contents of the cassette for use by the machine. The loading mechanism includes a base adapted for being fixedly mounted on the machine. The loading mechanism also includes a holder for releasably holding the cassette. The holder has one end pivotally connected to the base for pivoting about an axis for moving the cassette between a first position at which the holder releasably receives the cassette and a second position at which the cassette is placed in an operative relationship with the machine. The loading mechanism further includes a linkage mechanism coupled between the base and the holder for translating the holder along the axis as the holder is pivoted between the first and second positions.
Gregory D. Lewis - Cary NC Roger G. Roberts - Raleigh NC Thomas B. Givens - Rougemont NC
Assignee:
Akzo N.V. - Arnhem
International Classification:
G01N 2113 B65H 108
US Classification:
422 63
Abstract:
A cassette for storing and dispensing cuvettes and comprising an enclosable frame defining an interior volume for storing cuvettes. The frame includes a removable cover to aid in loading a plurality of cuvettes into the cassette. The frame also includes a side wall having a pivotally mounted door for pivoting between a closed position and an open position for dispensing the cuvettes from the cassette. And, the frame includes a locking mechanism for locking the door in the closed position to avoid an inadvertent dispensing of cuvettes. According to another aspect of the invention, a mechanism is provided for loading the cassette into an operative relationship with a machine for dispensing contents of the cassette for use by the machine. The loading mechanism includes a base adapted for being fixedly mounted on the machine. The loading mechanism also includes a holder for releasably holding the cassette.
Name / Title
Company / Classification
Phones & Addresses
Thomas Givens Chief Executive Officer
Council Capital Management, LLC Venture Capital Business · Misc Intermediation
Hemosonics, Llc
Vice President Research and Development
Independent Consultant Jan 2015 - Apr 2015
Principal Engineer
Liposcience Dec 2010 - Jan 2015
Senior Director, Engineering R and D
Bd Feb 2008 - Dec 2010
Principal Engineer
Biomerieux Nov 2002 - Dec 2007
Manager, R and D Biomathematics, It
Education:
Duke University
Masters, Mechanical Engineering
University of Tennessee, Knoxville
Bachelors, Biomedical Engineering
Skills:
Medical Devices R&D Fda Iso 13485 Product Development Life Sciences Design Control Biotechnology